IE56347B1 - 4-aminoalkyl-2(3h)-indolones - Google Patents

4-aminoalkyl-2(3h)-indolones

Info

Publication number
IE56347B1
IE56347B1 IE2866/83A IE286683A IE56347B1 IE 56347 B1 IE56347 B1 IE 56347B1 IE 2866/83 A IE2866/83 A IE 2866/83A IE 286683 A IE286683 A IE 286683A IE 56347 B1 IE56347 B1 IE 56347B1
Authority
IE
Ireland
Prior art keywords
compound
indolone
addition salt
acid addition
hydrogen
Prior art date
Application number
IE2866/83A
Other languages
English (en)
Other versions
IE832866L (en
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23776840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE56347(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of IE832866L publication Critical patent/IE832866L/en
Publication of IE56347B1 publication Critical patent/IE56347B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
IE2866/83A 1982-12-07 1983-12-06 4-aminoalkyl-2(3h)-indolones IE56347B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/447,564 US4452808A (en) 1982-12-07 1982-12-07 4-Aminoalkyl-2(3H)-indolones

Publications (2)

Publication Number Publication Date
IE832866L IE832866L (en) 1984-06-07
IE56347B1 true IE56347B1 (en) 1991-07-03

Family

ID=23776840

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2866/83A IE56347B1 (en) 1982-12-07 1983-12-06 4-aminoalkyl-2(3h)-indolones

Country Status (27)

Country Link
US (1) US4452808A (instruction)
EP (1) EP0113964B1 (instruction)
JP (1) JPS59112964A (instruction)
KR (1) KR910001042B1 (instruction)
AU (1) AU560170B2 (instruction)
BR (1) BR1100036A (instruction)
CA (1) CA1208650A (instruction)
CY (1) CY1497A (instruction)
CZ (1) CZ398191A3 (instruction)
DE (1) DE3367090D1 (instruction)
DK (1) DK156514C (instruction)
DZ (1) DZ587A1 (instruction)
EG (1) EG16556A (instruction)
ES (2) ES527827A0 (instruction)
FI (1) FI77849C (instruction)
GR (1) GR79121B (instruction)
HK (1) HK82089A (instruction)
IE (1) IE56347B1 (instruction)
IL (1) IL70311A (instruction)
LU (1) LU90097I2 (instruction)
NL (1) NL970005I2 (instruction)
NO (2) NO160135C (instruction)
NZ (1) NZ206344A (instruction)
PH (1) PH22067A (instruction)
PT (1) PT77739B (instruction)
ZA (1) ZA839094B (instruction)
ZW (1) ZW25883A1 (instruction)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588740A (en) * 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
GB8621040D0 (en) * 1986-08-30 1986-10-08 Smith Kline French Lab Process
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
KR20000035818A (ko) * 1996-08-27 2000-06-26 이곤 이 버그 4-아미노에톡시 인돌론 유도체
AR014847A1 (es) * 1998-04-13 2001-03-28 American Home Prod 4-amino-(etilamino)-oxindoles agonistas del autoreceptor de dopamina y una composicion farmaceutica que los comprende
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
FR2821843B1 (fr) * 2001-03-12 2003-05-09 Servier Lab Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
PT1545546E (pt) * 2002-09-13 2007-07-02 Motac Neuroscience Ltd Tratamento da discinesia com 2, 3-benzodiazepinas
WO2004026299A1 (en) * 2002-09-17 2004-04-01 Motac Neuroscience Limited Treatment of dyskinesia
ES2237307B1 (es) * 2003-10-14 2006-11-01 Urquima, S.A. Procedimiento para la preparacion de ropinirol.
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
NZ551542A (en) * 2004-05-11 2010-06-25 Egis Gyogyszergyar Nyrt Piperazine derivatives of alkyl oxindoles
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
EP1863484A1 (en) * 2005-03-21 2007-12-12 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
CN100457711C (zh) * 2005-06-27 2009-02-04 上海奥博生物医药技术有限公司 2-甲基-3-硝基苯基烷基胺衍生物或其盐的制备方法
WO2007010557A2 (en) * 2005-07-22 2007-01-25 Ind-Swift Laboratorie Limted Process for the preparation of highly pure ropinirole
ZA200809282B (en) 2006-03-29 2009-12-30 Alembic Ltd A process for the purification of ropinirole hydrochloride
MX2008012683A (es) * 2006-04-06 2009-01-07 Nupathe Inc Implantes para el tratamiento de estados asociados con dopamina.
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN100457732C (zh) * 2006-05-25 2009-02-04 药源药物化学（上海）有限公司 罗匹尼罗的制备方法
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
KR20100016270A (ko) * 2007-05-11 2010-02-12 산텐 세이야꾸 가부시키가이샤 비맥각계의 선택적 ｄ2 수용체 작용제를 유효 성분으로서 함유하는 후안부 질환의 예방 또는 치료제
US20090076124A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched ropinirole
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 一种罗匹尼罗的口服固体药物组合物
WO2010023693A2 (en) * 2008-09-01 2010-03-04 Lupin Limited Novel controlled release compositions of ropinirole
CA2738414C (en) 2008-09-29 2014-05-27 Wockhardt Research Centre Extended release dosage form of ropinirole
WO2010060070A2 (en) * 2008-11-24 2010-05-27 Auspex Pharmaceuticals, Inc. Indolinone modulators of dopamine receptor
CN102361638B (zh) 2009-05-21 2013-07-17 久光制药株式会社 经皮吸收制剂
EP2513055A1 (en) * 2009-12-16 2012-10-24 Pharmathen S.A. Process for the preparation of ropinirole and salts thereof
PH12012501777A1 (en) 2010-04-30 2012-11-12 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
CN101891641B (zh) * 2010-07-27 2015-06-10 北京华禧联合科技发展有限公司 盐酸罗匹尼罗关键中间体的稳定形态及其制备
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
WO2012129429A2 (en) 2011-03-24 2012-09-27 Teikoku Pharma Usa, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
US9913812B2 (en) 2011-11-09 2018-03-13 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
US9205061B2 (en) 2012-11-02 2015-12-08 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
WO2014092006A1 (ja) 2012-12-10 2014-06-19 キッセイ薬品工業株式会社 新規なオクタヒドロピリドキナゾリン誘導体、それを含有する医薬組成物およびそれらの用途
US9155695B2 (en) 2013-03-14 2015-10-13 Medtronic, Inc. Injectable ropinirole compositions and methods for making and using same
EP3640240B1 (en) 2017-06-16 2020-12-09 Zhejiang Huahai Licheng Pharmaceutical Co., Ltd. Method for purifying ropinirole hydrochloride
CN115466209A (zh) * 2022-09-29 2022-12-13 南通大学 一种罗匹尼罗环戊烷并吲哚酮杂质的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA895875A (en) * 1972-03-21 Bourdais Jacques Mercapto indole derivatives
US3573310A (en) * 1967-09-28 1971-03-30 Miles Lab 1-substituted derivatives of 2-indolinone
JPS5840539B2 (ja) * 1976-03-31 1983-09-06 大塚製薬株式会社 α−置換アミノアルカノイルオキシインド−ル誘導体
JPS5825673B2 (ja) * 1976-03-31 1983-05-28 大塚製薬株式会社 オキシインド−ル誘導体
JPS5919537B2 (ja) * 1976-08-02 1984-05-07 大塚製薬株式会社 オキシインド−ル誘導体
US4317944A (en) * 1980-08-15 1982-03-02 General Electric Company Preparation of 2,2-bis(4-hydroxyphenyl) propane
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones

Also Published As

Publication number Publication date
DE3367090D1 (de) 1986-11-27
HK82089A (en) 1989-10-20
KR840006963A (ko) 1984-12-04
PT77739B (en) 1986-03-27
NZ206344A (en) 1987-03-31
CY1497A (en) 1990-02-16
NO160135C (no) 1989-03-15
LU90097I2 (fr) 1997-07-16
NO160135B (no) 1988-12-05
EP0113964A1 (en) 1984-07-25
DK156514B (da) 1989-09-04
DK156514C (da) 1990-03-12
ZW25883A1 (en) 1984-04-18
NO1999011I1 (no) 1999-06-18
FI77849C (fi) 1989-05-10
DK562183A (da) 1984-06-08
US4452808A (en) 1984-06-05
FI77849B (fi) 1989-01-31
ES543593A0 (es) 1986-01-16
AU560170B2 (en) 1987-04-02
CZ398191A3 (en) 1993-02-17
PH22067A (en) 1988-05-20
BR1100036A (pt) 2000-01-11
KR910001042B1 (ko) 1991-02-21
ZA839094B (en) 1985-02-27
DK562183D0 (da) 1983-12-06
GR79121B (instruction) 1984-10-02
IL70311A0 (en) 1984-02-29
EP0113964B1 (en) 1986-10-22
IE832866L (en) 1984-06-07
IL70311A (en) 1986-11-30
AU2158583A (en) 1984-06-14
NO834485L (no) 1984-06-08
EG16556A (en) 1989-01-30
DZ587A1 (fr) 2004-09-13
ES8600239A1 (es) 1985-10-01
CA1208650A (en) 1986-07-29
JPS59112964A (ja) 1984-06-29
JPH0150703B2 (instruction) 1989-10-31
FI834421L (fi) 1984-06-08
ES527827A0 (es) 1985-10-01
NL970005I1 (nl) 1997-04-01
FI834421A0 (fi) 1983-12-02
PT77739A (en) 1983-12-01
ES8604143A1 (es) 1986-01-16
NL970005I2 (nl) 1997-10-01

Similar Documents

Publication Publication Date Title
EP0113964B1 (en) 4-aminoalkyl-2(3h)-indolones
EP0005528B1 (en) Imidazole derivatives, their preparation and pharmaceutical compositions
PL179561B1 (pl) oraz zawierajace je srodki lecznicze PL PL PL PL PL PL PL PL PL
NO177139B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-amidoindolylderivater
NZ212856A (en) Glutarimide derivatives and pharmaceutical compositions
JPH0739387B2 (ja) 新規１−ベンジル−アミノアルキル−ピロリジノン化合物及びその製造方法
CZ265096A3 (en) Thienoindole derivatives, their use, process of their preparation and pharmaceutical composition containing thereof
EP0162695B1 (en) 6-oxygenated-1,3,,4,5-tetrahydrobenz(cd)indol-4-amines
US4588740A (en) Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
EP0046666A1 (en) 2(3H)-indolones, process for their preparation and compositions containing them
EP0175525B1 (en) 7-[2-(Dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
FI79836C (fi) Foerfarande foer framstaellning av en farmaceutiskt aktiv n,n-di-n-propyl-4-hydroxi-3-metansulfonamidofenetylamin
EP0432648A2 (en) Isatine derivatives, their preparation and use
US6063964A (en) 5-hydroxymethyl-2-aminotetralins as cardiovascular agents
NO300375B1 (no) 6-okso-azepinoindolforbindelser, mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser
US4598093A (en) 4-amino-tetrahydro-2-naphthoic acid derivatives
US4414224A (en) Pharmaceutical composition and methods for producing dopamine agonist activity
CA2012569A1 (en) Benzothiopyranylamines
IE50006B1 (en) Derivatives of tetrahydropyrid-4-yl-indole
GB2113682A (en) 3,3 dialkyl or 3,3 alkene indolines
CA2005547C (en) Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones
JPS6040420B2 (ja) ３−アミノ−２−（５−フルオル−及び５−メトキシ−１ｈ−インド−ル−３−イル）プロパン酸誘導体類、その製法及び利用
EP0746556B1 (en) Tricyclic compounds having affinity for the 5-ht1a receptor
US4663482A (en) Intermediates for preparing 7-(2-aminoethyl)-1,3-benzthia- or oxa- zol-2(3H)-ones
JP3926284B2 (ja) 新規なインドリン化合物、その調製方法及びそれを含有する医薬組成物

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC 04/97 19960702

SPCG Supplementary protection certificate granted

Free format text: SPC 4/97

SPCG Supplementary protection certificate granted

Free format text: ON PAGE 347 OF JOURNAL NO.1814 OF 970618 THE FOLLOWING INFORMATION WAS OMITTED:SPC 4/97 CERTIFICATE EXPIRES ON 20081205

MK9A Patent expired